Showing results (41-50 of 52) with videos related to

Sort By:
Pageof 6
Blood Transfusion = Trasfusione Del Sangue|March 24, 2020
Effects of repleting organic phosphates in banked erythrocytes on plasma metabolites and vasoactive mediators after red cell exchange transfusion in sickle cell diseaseDenise A Lopez Domowicz, Ian Welsby, Charles R Esther, et al.
Molecular Neurobiology|May 31, 2020
Plasma Neurofilament Light Chain as a Translational Biomarker of Aging and Neurodegeneration in DogsWojciech K Panek, Margaret E Gruen, David M Murdoch, et al.
Rozhledy V Chirurgii : Mesicnik Ceskoslovenske Chirurgicke Spolecnosti|October 18, 2025
Total pancreatectomy with Langerhans islets autotransplantation for pancreatico-pleural fistula 2 years after pancreatoduodenectomy for chronic pancreatitisJ Hlavsa, P Moravčík, P Girman, et al.
Cancer Research|May 6, 2020
IL26, a Noncanonical Mediator of DNA Inflammatory Stimulation, Promotes TNBC Engraftment and Progression in Association with NeutrophilsTimothy N Trotter, Casey W Shuptrine, Li-Chung Tsao, et al.
Vaccines|November 26, 2024
Vaccination Against Androgen Receptor Splice Variants to Immunologically Target Prostate CancerRobert D Marek, Selena Halabi, Mu-En Wang, et al.
European Journal of Paediatric Neurology : EJPN : Official Journal of the European Paediatric Neurology Society|October 3, 2017
Mutations in AIFM1 cause an X-linked childhood cerebellar ataxia partially responsive to riboflavinG Heimer, E Eyal, X Zhu, et al.
Rozhledy V Chirurgii : Mesicnik Ceskoslovenske Chirurgicke Spolecnosti|February 10, 2025
Minimal invasive surgery of pancreatic cancer at the Department of Surgery of Masaryk university hospital Brno, Czech RepublicJ Hlavsa, T Pavlík, D Marek, et al.
NPJ Vaccines|March 17, 2026
Vector-directed immunity and boosting capacity of VRP-srRNA anti-tumor vaccinesXingru Ma, Robert D Marek, Susannah Gammell, et al.
Clinical Genetics|July 4, 2015
SLC1A4 mutations cause a novel disorder of intellectual disability, progressive microcephaly, spasticity and thin corpus callosumG Heimer, D Marek-Yagel, E Eyal, et al.
Human Vaccines & Immunotherapeutics|February 8, 2024
Vaccines targeting <i>ESR1</i> activating mutations elicit anti-tumor immune responses and suppress estrogen signaling in therapy resistant ER+ breast cancerGabrielle P Dailey, Christopher A Rabiola, Gangjun Lei, et al.
Pageof 6